相关实验视频
Updated: Jan 9, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
16.5K
机器学习预测原发性胃肠道黑色素瘤患者的整体存活率
1Department of Gastroenterology, Changshu Hospital Affiliated to Soochow University, First People's Hospital of Changshu City, Changshu, China.
Translational cancer research
|December 11, 2025
概括
这项研究开发了一种随机森林模型,用于预测原发性胃肠道黑色素瘤 (PGIM) 患者的整体存活率 (OS). 该模型准确预测存活率,有助于为这种罕见的癌症做出临床决策.
科学领域:
- 在瘤学瘤学.
- 机器学习在医学中的应用
- 癌症预后 癌症预后
背景情况:
- 初级胃肠道黑色素瘤 (PGIM) 是一种罕见的,具有有限生存预测工具的攻击性恶性瘤.
- 准确的预后模型对于改善患者的治疗结果和指导PGIM治疗策略至关重要.
研究的目的:
- 分析PGIM患者的临床特征.
- 在PGIM中开发和验证机器学习模型,用于预测1年,3年和5年的整体存活率 (OS).
主要方法:
- 来自SEER数据库 (2000-2021) 的1,060名PGIM患者的回顾性分析.
- 开发了六种生存预测模型 (Cox,LASSO,随机森林,XGBoost,GBM,神经网络).
- 使用C指数,AUC,Brier分数和决策曲线分析 (DCA) 的评估;通过SHAP解释性和变量重要性.
主要成果:
- 随机森林模型显示出优异的性能 (例如,训练集中的C指数为0.732).
- 该模型在测试集中显示出强大的通用性.
- 临床阶段,年龄和手术治疗被确定为关键的预后因素.
结论:
- 随机森林生存模型是一个有价值的,可概括的工具,用于预测PGIM患者的OS.
- 这个模型可以显著帮助临床决策和PGIM患者管理.
更多相关视频
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
470
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
625
相关概念视频
Cancer Survival Analysis
629
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
629
Kaplan-Meier Approach
536
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
536